Mechanisms of solute release from porous hydrophilic polymers | 1983/05/01 | English | 3,263 |
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | 2006/01/03 | English | 2,415 |
Nanocapsule formation by interfacial polymer deposition following solvent displacement | 1989/10/01 | English | 1,492 |
A simple equation for the description of solute release. III. Coupling of diffusion and relaxation | 1989/12/01 | English | 1,204 |
Cyclodextrins and their pharmaceutical applications | 2007/02/01 | English | 1,160 |
Polymer-based nanocapsules for drug delivery | 2010/01/01 | English | 1,137 |
Polymer microspheres for controlled drug release | 2004/09/01 | English | 930 |
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review | 2011/08/01 | English | 898 |
Mathematical modeling of drug delivery | 2008/12/01 | English | 897 |
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products | 2009/01/01 | English | 844 |
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications | 2011/11/01 | English | 774 |
Poly-ϵ-caprolactone microspheres and nanospheres: an overview | 2004/06/01 | English | 756 |
Protein aggregation and its inhibition in biopharmaceutics | 2005/01/01 | English | 708 |
Higuchi equation: Derivation, applications, use and misuse | 2011/10/01 | English | 693 |
Natural and synthetic polymers for wounds and burns dressing | 2014/03/01 | English | 677 |
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers | 1992/01/01 | English | 672 |
Chitosan microspheres as a potential carrier for drugs | 2004/04/01 | English | 658 |
In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid | 2011/01/01 | English | 636 |
Cyclodextrins | 2013/08/01 | English | 609 |
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability | 2021/05/01 | English | 605 |
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model | 2005/07/01 | English | 599 |
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles | 2008/12/01 | English | 582 |
Essential oils: From extraction to encapsulation | 2015/04/01 | English | 582 |
On the use of the Weibull function for the discernment of drug release mechanisms | 2006/02/01 | English | 562 |
Protein aggregation—Pathways and influencing factors | 2010/05/01 | English | 541 |
Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats | 2007/02/01 | English | 524 |
Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation | 2004/08/01 | English | 521 |
Formulation strategy and use of excipients in pulmonary drug delivery | 2010/06/15 | English | 503 |
Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products | 2008/11/01 | English | 502 |
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications | 2018/01/01 | English | 485 |